Jasper Therapeuti…
USUSDJasper Therapeutics, Inc. (US:JSPR) — Biotechnology: Biological Products (No Diagnostic Substances). Количество бирж, на которых торгуются акции компании: 1. На этой странице — цена и график, дивиденды, крупнейшие держатели и история количества акций.
О Компании
- Сайт
- jaspertx.com
- Сектор
- Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
- Штаб-Квартира
- REDWOOD CITY, United States
- Акций в Обращении
- 33.27 млн на 2026-08-10
- Рыночная Капитализация
- 20.83 млн USD
- Инсайдеры
- 2.87%
- Институциональные Инвесторы
- 39.43%
- Отрасль (SIC)
- Biological Products, (No Diagnostic Substances)
- P/E
- убыток
- FCF
- −60.3 млн USD
- Долг
- 400 тыс USDденег больше, чем долга
- Прибыль и FCF — за 12 месяцев до 30.06.2026 года (последний отчет компании).
Описание
Jasper Therapeutics, Inc., a clinical stage biotechnology company, focuses on the design and development of therapies to treat immune-mediated diseases. It is advancing a pipeline of medicines, including KP-104, a dual-complement inhibitor that has demonstrated positive outcomes in paroxysmal nocturnal hemoglobinuria (PNH) and is under evaluation in other unmet need nephrology disorders; Briquilimab is an anti-KIT antibody, which has demonstrated clinical results as a conditioning agent for stem cell transplant and mast cell mediated diseases, such as chronic urticarias and allergic asthma; and KP-701, a novel, dual-acting anti-CD79BxCD32B monoclonal antibody (mAb) for autoantibody-mediated disorders. The company is based in Redwood City, California.
Биржи и Тикеры
| Биржа | Тикер | Валюта | Цена | Тип |
|---|---|---|---|---|
| US USA Stocks | JSPR | USD | 0.555 -2.67% | обыкновенные акции |
Крупнейшие Держатели
| Держатель | Доля | Акции | Дата Отчета |
|---|---|---|---|
| Velan Capital Investment… | 16.04% | 5.34 млн | 2026-06-30 |
| Acorn Capital Advisors,… | 8.64% | 2.88 млн | 2026-06-30 |
| Kingdon Capital Manageme… | 8.13% | 2.7 млн | 2026-06-30 |
| Vanguard Capital Managem… | 7.04% | 2.34 млн | 2026-06-30 |
| Rock Springs Capital Man… | 6.62% | 2.2 млн | 2026-06-30 |
| Carlyle Group Inc. | 6.41% | 2.13 млн | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 5.01% | 1.67 млн | 2026-06-30 |
| GSA Capital Partners LLP | 3.21% | 1.07 млн | 2026-06-30 |
| Millennium Management Ll… | 2.93% | 973 866 | 2026-06-30 |
| Lion Point Capital, LP | 2.79% | 930 000 | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 1.88% | 624 064 | 2026-06-30 |
| Geode Capital Management… | 1.59% | 527 616 | 2026-06-30 |
| SHIZURU JUDITH ANNE M.D.… | ≈0.47% | 156 901 | 2025-09-22 |
| Fidelity Concord Street… | 0.38% | 127 525 | 2026-07-31 |
| MARTELL RONALD A (Chief… | ≈0.22% | 74 118 | 2025-09-22 |
| VANGUARD VALLEY FORGE FU… | 0.16% | 53 196 | 2026-06-30 |
| Fidelity Concord Street… | 0.15% | 49 896 | 2026-07-31 |
| Fidelity Concord Street… | 0.1% | 34 109 | 2026-07-31 |
| MAHAL JEETINDER SINGH (C… | ≈0.08% | 25 009 | 2024-12-12 |
| LUCAS SVETLANA (Director… | ≈0.06% | 20 000 | 2025-09-22 |
| ADVISORS' INNER CIRCLE I… | 0% | 292 | 2026-04-30 |
| WIGGANS THOMAS G (Direct… | — | — | 2025-09-22 |
